• 1. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 2. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Comprehensive Overview of 1-(5,6-Dimethylpyridin-3-YL)ethanone (CAS No. 1211535-68-0): Properties, Applications, and Industry Insights

1-(5,6-Dimethylpyridin-3-YL)ethanone (CAS No. 1211535-68-0) is a specialized organic compound belonging to the pyridine derivative family. With its unique molecular structure featuring a dimethylpyridine core and an acetyl functional group, this compound has garnered significant attention in pharmaceutical and agrochemical research. The CAS 1211535-68-0 identifier ensures precise tracking in global chemical databases, making it indispensable for regulatory compliance and supply chain management.

Recent studies highlight the growing demand for pyridine-based intermediates like 1-(5,6-Dimethylpyridin-3-YL)ethanone in drug discovery programs. Its structural versatility allows for modifications that enhance bioavailability and target specificity—key factors driving its use in developing kinase inhibitors and anti-inflammatory agents. Researchers particularly value its electron-rich aromatic system, which facilitates selective bond formations in catalytic reactions.

From an industrial perspective, CAS 1211535-68-0 aligns with sustainability trends through efficient synthetic routes that minimize hazardous byproducts. Advanced purification techniques such as crystallization and chromatography ensure >98% purity, meeting stringent standards for high-value chemical synthesis. These processes address frequent search queries like "green chemistry approaches for pyridine derivatives" and "scalable production of heterocyclic ketones".

The compound's thermal stability (decomposition point >200°C) and solubility profile (soluble in polar aprotic solvents) make it ideal for high-temperature reactions—a topic trending in material science forums. Analytical characterization via NMR, HPLC-MS, and FTIR confirms its structural integrity, while computational modeling predicts potential applications in organic electronics and catalysis.

Market analysts note increased patent filings involving 1-(5,6-Dimethylpyridin-3-YL)ethanone, particularly in Asia-Pacific regions where fine chemical manufacturing is expanding. This correlates with search trends for "pyridine export regulations" and "specialty chemical suppliers". The compound's low ecotoxicity (OECD 301D certified) further supports its adoption in environmentally conscious formulations.

Ongoing research explores its utility in photoredox catalysis—a cutting-edge field addressing energy-efficient synthesis. Such innovations respond to frequent queries like "visible-light-mediated pyridine functionalization". With global demand projected to grow at 6.2% CAGR (2023-2030), CAS 1211535-68-0 represents a strategic asset for R&D portfolios targeting next-generation therapeutics and advanced materials.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)